Synthesis of Enantioenriched Azaborole Helicenes by Chirality Transfer from Axially Chiral Biaryls

Felix Full; Martijn J. Wildervanck; Daniel Volland; Agnieszka Nowak-Król

doi:10.1055/a-1914-1799

Synlett, Table of Contents

Synlett 2023; 34(05): 477-482
DOI: 10.1055/a-1914-1799

cluster

Special Edition Thieme Chemistry Journals Awardees 2022

Synthesis of Enantioenriched Azaborole Helicenes by Chirality Transfer from Axially Chiral Biaryls

Felix Full

,

Martijn J. Wildervanck

,

Daniel Volland

,

Agnieszka Nowak-Król ∗

Abstract

All articles of this category

Dedicated to Professor Holger Braunschweig on the occasion of his 60^th birthday

Abstract

We report the enantioselective synthesis of azaborole helicenes from enantioenriched axially chiral precursors. The borylation/metal-exchange reaction sequence affords the target compounds with full transfer of chirality from the corresponding biaryls. Experimental studies provided insights into the configurational stability of the heterobiaryls and their (chir)optical properties. The structure of the phenyl-substituted helicene was unambiguously confirmed by single-crystal X-ray analysis.

Key words

axial chirality - azaboroles - borylation - chirality transfer - helicenes - configurational stability

Full Text

References

References and Notes

1a Mori T. Chem. Rev. 2021; 121: 2373
1b Zhao W.-L, Li M, Lu H.-Y, Chen C.-F. Chem. Commun. 2019; 55: 13793
1c Yuan K, Volland D, Kirschner S, Uzelac M, Nichol GS, Nowak-Król A, Ingleson MJ. Chem. Sci. 2022; 13: 1136
1d Chen C.-F, Shen Y. Helicene Cemistry, Springer: Berlin, 2017.

2a Aillard P, Voituriez A, Dova D, Cauteruccio S, Licandro E, Marinetti A. Chem. Eur. J. 2014; 20: 12373
2b Gingras M. Chem. Soc. Rev. 2013; 42: 1051

3a Dhbaibi K, Favereau L, Crassous J. Chem. Rev. 2019; 119: 8846
3b Gingras M, Félix G, Peresutti R. Chem. Soc. Rev. 2013; 42: 1007

4a Brandt JR, Salerno F, Fuchter MJ. Nat. Rev. Chem. 2017; 1: 0045
4b Shen Y, Chen C.-F. Chem. Rev. 2012; 112: 1463

5a Klívar J, Šámal M, Jančařík A, Vacek J, Bednárová L, Buděšínský M, Fiedler P, Starý I, Stará IG. Eur. J. Org. Chem. 2018; 2018: 5164
5b Teplý F, Stará IG, Starý I, Kollárovič A, Šaman D, Vyskočil Š, Fiedler P. J. Org. Chem. 2003; 68: 5193
5c Hanada K, Nogami J, Miyamoto K, Hayase N, Nagashima Y, Tanaka Y, Muranaka A, Uchiyama M, Tanaka K. Chem. Eur. J. 2021; 27: 9313
5d Murayama K, Oike Y, Furumi S, Takeuchi M, Noguchi K, Tanaka K. Eur. J. Org. Chem. 2015; 1409
5e Heller B, Hapke M, Fischer C, Andronova A, Starý I, Stará IG. J. Organomet. Chem. 2013; 723: 98
5f Shibata T, Uchiyama T, Yoshinami Y, Takayasu S, Tsuchikama K, Endo K. Chem. Commun. 2012; 48: 1311

6a Nakamura K, Furumi S, Takeuchi M, Shibuya T, Tanaka K. J. Am. Chem. Soc. 2014; 136: 5555
6b Satoh M, Shibata Y, Tanaka K. Chem. Eur. J. 2018; 24: 5434
6c Hartung T, Machleid R, Simon M, Golz C, Alcarazo M. Angew. Chem. Int. Ed. 2020; 59: 5660
6d Pelliccioli V, Hartung T, Simon M, Golz C, Licandro E, Cauteruccio S, Alcarazo M. Angew. Chem. Int. Ed. 2022; 61: e202114577

7 Kötzner L, Webber MJ, Martínez A, De Fusco C, List B. Angew. Chem. Int. Ed. 2014; 53: 5202

8a Liu P, Bao X, Naubron J.-V, Chentouf S, Humbel S, Vanthuyne N, Jean M, Giordano L, Rodriguez J, Bonne D. J. Am. Chem. Soc. 2020; 142: 16199
8b Jia S, Li S, Liu Y, Qin W, Yan H. Angew. Chem. Int. Ed. 2019; 58: 18496

9a Šámal M, Chercheja S, Rybáček J, Vacek Chocholoušová J, Vacek J, Bednárová L, Šaman D, Stará IG, Starý I. J. Am. Chem. Soc. 2015; 137: 8469
9b Crittall MR, Fairhurst NW. G, Carbery DR. Chem. Commun. 2012; 48: 11181

10 Dhawa U, Tian C, Wdowik T, Oliveira JC. A, Hao J, Ackermann L. Angew. Chem. Int. Ed. 2020; 59: 13451

11a Weimar M, Correa da Costa R, Lee F.-H, Fuchter MJ. Org. Lett. 2013; 15: 1706
11b Kaneko E, Matsumoto Y, Kamikawa K. Chem. Eur. J. 2013; 19: 11837

12 Nakano K, Hidehira Y, Takahashi K, Hiyama T, Nozaki K. Angew. Chem. Int. Ed. 2005; 44: 7136

13a Murai T, Xing Y, Kuribayashi T, Lu W, Guo J.-D, Yella R, Hamada S, Sasamori T, Tokitoh N, Kawabata T, Furuta T. Chem. Pharm. Bull. 2018; 66: 1203
13b Murai T, Xing Y, Kurokawa M, Kuribayashi T, Nikaido M, Elboray EE, Hamada S, Kobayashi Y, Sasamori T, Kawabata T, Furuta T. J. Org. Chem. 2022; 87: 5510

14 Terrasson V, Roy M, Moutard S, Lafontaine M.-P, Pèpe G, Félix G, Gingras M. RSC Adv. 2014; 4: 32412
15 Full F, Wölflick Q, Radacki K, Braunschweig H, Nowak-Król A. Chem. Eur. J. 2022; in press; DOI
16 Full J, Panchal SP, Götz J, Krause A.-M, Nowak-Król A. Angew. Chem. Int. Ed. 2021; 60: 4350

17a Zheng J, You S.-L. Angew. Chem. Int. Ed. 2014; 53: 13244ee
17b Wang Q, Zhang W.-W, Zheng C, Gu Q, You S.-L. J. Am. Chem. Soc. 2021; 143: 114

18a Carmona JA, Rodríguez-Franco C, Fernández R, Hornillos V, Lassaletta JM. Chem. Soc. Rev. 2021; 50: 2968
18b Wencel-Delord J, Panossian A, Leroux FR, Colobert F. Chem. Soc. Rev. 2015; 44: 3418
18c Bringmann G, Price Mortimer AJ, Keller PA, Gresser MJ, Garner J, Breuning M. Angew. Chem. Int. Ed. 2005; 44: 5384

19 Trapp O. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008; 875: 42
20 Watson AA, Willis AC, Wild SB. J. Organomet. Chem. 1993; 445: 71
21 Tan JS. J, Paton RS. Chem. Sci. 2019; 10: 2285
22 (M)-EH3-Me₂: Enantioselective SynthesisEnantioenriched (R _a)-BA3 (96% ee) (16.0 mg, 31.6 μmol, 1.0 equiv) was dissolved in CH₂Cl₂ (1.5 mL) under argon. DIPEA (5.90 μL, 4.50 mg, 34.8 μmol, 1.1 equiv) was added and the mixture was cooled to –78 °C. A 1.0 M solution of BBr₃ in CH₂Cl₂ (95.0 µL, 95.0 μmol, 3.0 equiv) was added dropwise, and the mixture was warmed to rt and stirred at rt for 22 h. The solvent was removed in vacuo and the resulting orange solid was washed with dry hexane (3 × 1 mL) under argon. The resulting residue was dissolved in CH₂Cl₂ (2 mL), and a 2.0 M solution of AlMe₃ in toluene (46.7 μL, 93.3 µmol, 3.0 equiv) was added dropwise to the mixture under argon. The resulting mixture was stirred at rt for 1 h, then cooled to 0 °C. H₂O (2 mL) was added and the mixture was extracted with CH₂Cl₂ (4 × 5 mL). The combined organic phases were then dried (MgSO₄), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica hexane/EtOAc (4:1)] to give a yellow solid; yield: 6.00 mg (11.0 μmol, 35%, 96% ee).HPLC: Reprosil Chiral-MIF, 250 × 4.6 mm, hexane–CH₂Cl₂ (87:13), 2 mL/min. ¹H NMR (400 MHz, CD₂Cl₂): δ = 8.88 (d, J = 7.9 Hz, 1 H, Ar-H), 8.83–8.74 (m, 3 H, Ar-H), 8.59 (d, J = 7.7 Hz, 1 H, Ar-H), 8.55 (d, J = 5.8 Hz, 1 H, Ar-H), 8.17 (d, J = 8.2, 1 H, Ar-H), 8.10 (d, J = 7.8 Hz, 1 H, Ar-H), 7.98 (d, J = 8.7 Hz, 1 H, Ar-H), 7.83 (d, J = 5.8 Hz, 1 H, Ar-H), 7.82–7.74 (m, 3 H, Ar-H), 7.34–7.70 (m, 2 H, Ar-H), 7.67 (d, J = 7.9 Hz, 1 H, Ar-H), 7.52 (d, J = 8.3, 1 H, Ar-H), 7.37 (t, J = 8.2, 1 H, Ar-H), 7.26 (d, J = 8.2 Hz, 1 H, Ar-H), 6.99 (t, J = 7.2 Hz, 1 H, Ar-H), 6.59 (t, J = 7.2 Hz, 1 H, Ar-H), 6.38 (t, J = 7.2 Hz, 1 H, Ar-H), 0.37 (s, 3 H, CH₃), 0.20 (s, 3 H, CH₃).The synthesis of (P)-EH3-Me₂ from (S _a)-BA3 is described in the SI.
23 CCDC 2182824 contains the supplementary crystallographic data for compound EH3-Ph₂ . The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures.
24 (M)-EH3-Ph₂: Enantioselective SynthesisEnantioenriched (R _a)-BA3 (98% ee) (6.00 mg, 11.9 μmol, 1.0 equiv) was dissolved in CH₂Cl₂ (0.75 mL) under argon. DIPEA (2.20 μL, 1.69 mg, 13.1 μmol, 1.1 equiv) was added and the mixture was cooled to –78 °C. A 1.0 M solution of BBr₃ in CH₂Cl₂ (35.6 μL, 35.6 μmol, 3.0 equiv) was added dropwise, and the mixture was warmed to rt and stirred at rt for 22 h. The solvent was then removed in vacuo and the resulting orange solid was washed with dry hexane (3 × 0.5 mL) under argon. The residue was dissolved in toluene (0.75 mL) and a 1.0 M solution of AlPh₃ in Et₂O (35.5 μL, 35.5 µmol, 3.0 equiv) was added dropwise under argon. The resulting mixture was stirred at 90 °C for 4 h, then cooled to 0 °C. H₂O (1.5 mL) was added and the mixture was extracted with EtOAc (4 × 3 mL). The combined organic phases were dried (MgSO₄), filtered, and concentrated in vacuo. The residue was purified by column chromatography [silica , cyclohexane/CH₂Cl₂ (3:1)] to give a yellow solid; yield: 4.50 mg (6.72 μmol, 57%, 98% ee). HPLC: Reprosil Chiral-MIF, 250 × 4.6 mm, hexane–CH₂Cl₂ (87:13), 2 mL/min (For details, see SI). ¹H NMR (400 MHz, CD₂Cl₂) δ = 8.89 (d, J = 8.0 Hz, 1 H, Ar-H), 8.81–8.69 (m, 3 H, Ar-H), 8.61–8.57 (m, 1 H, Ar-H), 8.56 (d, J = 5.9 Hz, 1 H, Ar-H), 8.18 (d, J = 8.5 Hz, 1 H, Ar-H), 8.14 (d, J = 8.0 Hz, 1 H, Ar-H), 8.03 (d, J = 8.6 Hz, 1 H, Ar-H), 7.82 (d, J = 5.9 Hz, 1 H, Ar-H), 7.81–7.63 (m, 6 H, Ar-H), 7.60 (d, J = 8.5 Hz, 1 H, Ar-H), 7.56–7.52 (m, 2 H, Ar-H), 7.41 (ddd, J = 8.0, 7.0, 1.1 Hz, 1 H, Ar-H), 7.38–7.27 (m, 5 H, Ar-H), 7.26–7.20 (m, 1 H, Ar-H), 7.16–7.07 (m, 3 H, Ar-H), 7.02 (ddd, J = 8.3, 7.1, 1.4 Hz, 1 H, Ar-H), 6.64 (ddd, J = 8.4, 6.9, 1.2 Hz, 1 H, Ar-H), 6.43 (ddd, J = 8.3, 7.1, 1.2 Hz, 1 H, Ar-H).The syntheses of (P)-EH3-Ph₂ from (S _a)-BA3 and of rac-EH3-Ph₂ from rac-BA3 are described in the SI.

Supplementary Material

Supporting Information